Loading...
XSHE002727
Market cap963mUSD
Jan 14, Last price  
12.24CNY
1D
2.00%
1Q
-8.25%
Jan 2017
-42.26%
IPO
26.64%
Name

Yixintang Pharmaceutical Group Co Ltd

Chart & Performance

D1W1MN
XSHE:002727 chart
P/E
12.85
P/S
0.41
EPS
0.95
Div Yield, %
3.38%
Shrs. gr., 5y
1.00%
Rev. gr., 5y
13.52%
Revenues
17.30b
-0.75%
1,455,978,4521,850,165,9422,218,508,2232,842,139,5363,546,662,0614,428,409,9885,321,152,3306,249,335,7167,751,139,4139,176,269,66810,479,093,10512,656,284,25914,587,401,32417,431,615,60417,301,378,940
Net income
549m
-45.60%
84,848,843102,945,179134,709,500182,551,396240,853,271297,309,133346,438,643353,377,013422,714,107521,069,744603,917,846789,960,226921,583,5671,009,996,157549,441,525
CFO
2.12b
-15.29%
00101,552,738157,665,390228,224,995176,218,848185,760,455192,632,310391,156,158635,771,681982,923,9591,033,358,9771,791,674,0422,497,100,4782,115,339,452
Dividend
May 30, 20240.4 CNY/sh

Profile

Yixintang Pharmaceutical Group Co., Ltd., together with its subsidiary, operates a chain of drugstores in China. It also produces and sells medicinal materials, Chinese herbal medicines, and food and health products, as well as engages in the drug distribution activities. As of January 31, 2020, the company operated 7,205 stores in Yunnan, Guizhou, Guangxi, Sichuan, Shanxi, Chongqing, Tianjin, Shanghai, Qiong, and other provinces and municipalities. It also sells products online. The company was formerly known as Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd. and changed its name to Yixintang Pharmaceutical Group Co., Ltd. in June 2019. Yixintang Pharmaceutical Group Co., Ltd. was founded in 2000 and is headquartered in Kunming, China.
URL
https://www.yixintanggroup.com/
IPO date
Jul 02, 2014
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
17,301,379
-0.75%
17,431,616
19.50%
Cost of revenue
12,480,034
15,469,970
Unusual Expense (Income)
NOPBT
4,821,345
1,961,646
NOPBT Margin
27.87%
11.25%
Operating Taxes
142,151
222,000
Tax Rate
2.95%
11.32%
NOPAT
4,679,194
1,739,645
Net income
549,442
-45.60%
1,009,996
9.59%
Dividends
(238,409)
(178,854)
Dividend yield
1.72%
0.95%
Proceeds from repurchase of equity
(343)
BB yield
0.00%
Debt
Debt current
470,399
1,335,537
Long-term debt
3,104,339
3,515,218
Deferred revenue
1,245
12,154
Other long-term liabilities
13,297
1
Net debt
(485,895)
1,199,326
Cash flow
Cash from operating activities
2,115,339
2,497,100
CAPEX
(253,463)
Cash from investing activities
(543,063)
Cash from financing activities
(1,447,009)
FCF
5,073,492
1,849,734
Balance
Cash
3,895,293
3,519,989
Long term investments
165,341
131,441
Excess cash
3,195,565
2,779,848
Stockholders' equity
5,373,458
5,457,737
Invested Capital
6,718,562
7,603,556
ROIC
65.34%
22.84%
ROCE
48.61%
18.88%
EV
Common stock shares outstanding
596,830
595,236
Price
23.16
-26.50%
31.51
-18.18%
Market cap
13,822,578
-26.30%
18,755,881
-17.77%
EV
13,467,718
20,056,645
EBITDA
5,979,271
2,962,285
EV/EBITDA
2.25
6.77
Interest
135,339
147,123
Interest/NOPBT
2.81%
7.50%